⌘K

Login Start Free

Home/Filings/4/0001193125-25-228920

4//SEC Filing

Azam Usman 4

Accession 0001193125-25-228920

CIK 0001645460other

View on SEC.gov Company Profile

Filed

Oct 1, 8:00 PM ET

Accepted

Oct 2, 8:13 PM ET

Size

5.3 KB

Accession

0001193125-25-228920

Insider Transaction Report

Form 4

Period: 2025-09-29

Cue Biopharma, Inc.CUE

DirectorCHIEF EXECUTIVE OFFICER

Transactions

Award
Stock Option (right to buy)
2025-09-29+1,875,000→ 1,875,000 total
Exercise: $0.72Exp: 2035-09-28→ Common Stock (1,875,000 underlying)

Footnotes (1)

[F1]This stock option becomes exercisable in 48 monthly installments beginning on September 29, 2026.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Cue Biopharma, Inc.

CIK 0001645460

Entity typeother

Related Parties

1

filerCIK 0002089768

Filing Metadata

Form type: 4
Filed: Oct 1, 8:00 PM ET
Accepted: Oct 2, 8:13 PM ET
Size: 5.3 KB

View on SEC.gov